ArticleBMC medical imaging2024

Development and validation of peritumoral vascular and intratumoral radiomics to predict pathologic complete responses to neoadjuvant chemotherapy in patients with triple-negative breast cancer.

Tianwen Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.